Jessica Dawson

Apr 12, 2024 | onlinelibrary.wiley.com | Jessica Dawson |Tarun Bastiampillai

1 INTRODUCTION Clozapine is the gold standard for treatment resistant schizophrenia.1 Patients who are prescribed clozapine, require regular monitoring for clozapine-associated neutropenia (CAN) and clozapine-induced agranulocytosis (CIA) sometimes referred to as severe neutropenia.2 A meta-analysis estimates that the overall incidence rate of mild CAN and CIA is 3.8% and 0.9%, respectively.3 Mortality associated with neutropenia in clozapine-treated patients is extremely rare (0.013%).3 The...